DBDawn Bowles

Dawn Bowles

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dawn Bowles has a total of 230 co-authors. Here are the top co-authors by number of shared publications:

  • Michelle Mendiola Pla

    Department of Surgery, Duke University, Durham, NC 27710, USA

    9 shared publications
  • Michelle Mendiola Pla

    Division of Cardiothoracic Surgery, Duke University Medical Center, Durham, NC, United States

    7 shared publications
  • Carmelo A. Milano

    Division of Cardiothoracic Surgery, Duke University Medical Center, Durham, NC, United States

    6 shared publications
  • Franklin H. Lee

    Division of Surgical Sciences, Duke University Medical Center, Durham, NC, USA

    5 shared publications
  • Yuting Chiang

    Division of Cardiovascular and Thoracic Surgery, Aurora St. Luke’s Medical Center, Milwaukee, WI, United States

    5 shared publications
  • Amy Evans

    Perfusion Services, Duke University Medical Center, Durham, NC, United States

    4 shared publications

Latest Publications

  • Open Access

    Integrative Molecular Analyses of Inflammatory and Autoimmune Signals in Cardiac Sarcoidosis

    by Meraj Neyazi, Gabriela Venturini, Kemar J. Brown, Youjung Choi, Joshua M. Gorham, Olivia G. Layton, Arjun Verma, Adam J. Wang, Ryan T. Gross, Barbara A. McDonough, et al.

    BACKGROUND: Cardiac sarcoidosis (CS) is an enigmatic disorder characterized by unexplained patchy, sterile granulomas intermixed with preserved myocardium and fibrotic regions without granuloma. CS causes arrhythmias, sudden cardiac death, and heart failure. The mechanisms producing this remarkable histopathology and disease progression remain unexplained. METHODS: Using comprehensive single-cell and spatial transcriptomic analyses, we characterized the cellular composition and gene expression in preserved, granulomatous, and fibrotic regions of human CS hearts. From unexpectedly identified clonally expanded cardiac B cells with rearranged immunoglobulin sequences, we reconstructed antibodies and screened libraries comprising the human peptidome or microbial and allergen peptides to define reactive epitopes in CS hearts. RESULTS: Cellular composition and gene expression differed substantially in CS tissues with preserved, granulomatous, or fibrotic histopathology. Cardiomyocytes upregulated arrhythmogenic and inflammasome transcripts associated with pyroptosis. Cardiomyocytes and fibroblasts activated chemoattractant cytokines that sustained myeloid and lymphoid infiltration. Granulomas contained abundant macrophages expressing modulators of cell–cell fusion, along with Th17-skewed T cells that upregulated B-cell–activating factor, thereby promoting antibody production. Fibrotic regions, without active granulomas, exhibited tertiary lymphoid structures, with clonal expansion of mature B and plasma cells. Reconstructed antibodies derived from expanded B-cell clones were inert to microbial and allergen peptides, but reacted to PPL (periplakin), a desmosome protein, and other peptides expressed on cardiac cells. CONCLUSIONS: Progressive inflammatory signals in CS are mediated by chemoattractant genes in cardiomyocytes and fibroblasts within preserved myocardium, cell–cell fusion modulators in activated macrophages within granulomatous regions, and tertiary lymphoid structures in fibrotic regions that produce patient-specific autoimmune antibodies. Identification of PPL as a CS autoantigen may account for shared clinical manifestations in CS and arrhythmic desmosomal cardiomyopathies. CS autoantigens may underlie enigmatic histopathologic findings, perpetuate disease, and contribute to adverse outcomes. Uncovering an intracardiac humoral autoimmune axis in CS provides specific therapeutic opportunities to limit granuloma formation and B-cell activation, which may reduce arrhythmogenicity and progressive dysfunction. Parallel analytic strategies have potential to define autoantigens in other enigmatic cardiac immune disorders.


  • Open Access

    Double-stranded RNA and reverse transcriptase signatures of endogenous retroviruses after exposure to spaceflight environment related stressors

    by Michelle Mendiola Pla, Franklin H. Lee, Matthew F. Smith, Alejandro Alvarez Lobo, Thomas E. Diaz, Adam S. Cockrell, Dawn E. Bowles

  • Open Access

    Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension

    by Yongneng Zhang, Sébastien Bonnet, Steeve Provencher, Jiyuan Piao, Alois Haromy, Yongsheng Liu, Yuan-Yuan Zhao, Sandra Breuils-Bonnet, Sarah-Eve Lemay, Dawn E. Bowles, et al.

    BACKGROUND: Right ventricular failure drives both morbidity and mortality in pulmonary arterial hypertension (PAH), but the mechanism of transition from compensated right ventricle (cRV) to decompensated RV (dRV) is unknown, and some PAH patients develop dRV faster than others. METHODS: We explored the role of RV cardiac myofibroblasts (cMFBs) on this transition utilizing 2 rat models: monocrotaline (MCT) versus the less inflammatory pulmonary artery banding (PAB); and 3 patient cohorts (n=81) of PAH versus group 2 pulmonary hypertension (PHT-2). We hypothesized that loss of UCP2 (uncoupling protein 2), critical for mitochondrial calcium (mCa ++ ) regulation and cardiac fibroblasts (cFBs) differentiation to cMFBs, is associated with dRV; and that a loss-of-function UCP2 single nucleotide polymorphism (SNP; rs659366) may predict dRV in human PAH. RESULTS: We separated rat cRV from dRV based on catheterization and echocardiographic criteria and found a significant increase in cMFBs from MCT but not PAB RV (which decompensated much later than MCT RV). In isolated hearts, MCT RV contractility was lower in dRV but not in isolated cardiomyocytes (CMs), pointing to a non-CM cause. Mitochondrial respiration was lower in MCT dRV cMFBs than in control and cRV cFBs but increased in MCT–RV CMs. mCa ++ was progressively decreased from normal to MCT–cRV to dRV cMFBs, and the same was true for c(M)FBs (but not CMs) UCP2. Tumor necrosis factor alpha (TNF-α) decreased UCP2 mRNA/protein levels in RV cFBs but not RV CMs. In human PAH, but not PHT-2, dRVs had more cMFBs and less UCP2 than control and cRVs. Decreased UCP2 levels and rs659366 were associated with worse RV performance (tricuspid annular plane systolic excursion and cardiac index), even among patients with similar mean pulmonary arterial pressure. CONCLUSIONS: Our data suggest that a change of cell identity (cFBs to cMFBs) in the RV is a driver of RV decompensation. TNF-α or rs659366 is a potential biomarker for early RV decompensation in PAH.


  • Selective translation of ZNF281 as part of the integrated stress response system has therapeutic relevance for cardio-oncology

    by Maria Areli Lorenzana-Carrillo, Saymon Tejay, Guocheng Huang, Joseph Nanoa, Yuan-Yuan Zhao, Cory Wagg, Farah Eaton, Michelle Mendiola Pla, Dawn E. Bowles, Adam Kinnaird, et al.

    A well-recognized attribute of several common and standard cancer therapeutics is the development of cardiotoxicity. Although many anticancer agents appear to target a relatively select and distinct signaling pathway in the tumor, we hypothesized that several different classes of chemotherapeutics may converge into one central stress-sensing system in terminally differentiated cardiomyocytes. Here, we showed that anticancer intercalating/alkylating agents, tyrosine kinase inhibitors, or receptor inhibitors can converge and increase the selective and preferential translation of the transcription factor ZNF281 in cardiomyocytes. Cardiomyocyte-specific ZNF281-deficient mice were completely resistant to anthracycline-mediated cardiotoxicity (AIC), whereas cardiomyocyte-specific ZNF281-overexpressing mice had clinical features of cardiotoxicity. Inhibition of ZNF281 with ZIM, a first-of-its-kind small-molecule drug, completely prevented AIC, enhanced lung tumor regression, and prevented lung metastasis in a metastatic melanoma model. Induction of ZNF281, along with its downstream signaling cascade, was preserved in myocardial tissues from patients with AIC, indicating the translational potential of ZNF281 inhibition in alleviating cardiotoxicity resulting from chemotherapeutic treatments.


  • Open Access

    Reconstitution of thymopoiesis via implantation of cryopreserved cultured thymus tissue into athymic recipients

    by Laura P. Hale, Dawn E. Bowles, Jie Li, Andrew N. Macintyre, NiDajah Bolden, Joanne Kurtzberg, Cathlyn K. Medina, Berk Aykut, Elisabeth T. Tracy, Joseph W. Turek


  • Open Access

    A porcine model of acute rejection for cardiac transplantation

    by Michelle Mendiola Pla, Yuting Chiang, Carolyn Glass, David C. Wendell, Devjanee Swain-Lenz, Sam Ho, Marat Fudim, Franklin H. Lee, Lillian Kang, Matthew F. Smith, et al.

    Ex vivo machine perfusion has been growing in utility for preserving donor organs prior to transplantation. This modality has tremendous potential for bioengineering and conditioning organs prior to transplantation using small molecule or advanced therapeutics. To safely translate potential interventions, well characterized models of disease are crucial for testing the therapeutic and possible side effects that could manifest from the interventions. Acute cellular rejection remains a significant complication in organ transplantation that affects transplant recipients with significant morbidity and mortality. This disease could potentially be mitigated with therapeutic intervention during ex vivo machine perfusion. A porcine animal model of acute rejection could be characterized in order to translate human biological processes with high fidelity. The Yucatan pig breed has been increasingly used in both biomedical research and xenotransplantation applications given its similarity to the human heart. A challenge with utilizing this pig breed for designing a model of acute rejection is its highly conserved ancestral lineage, which could make it difficult to induce acute rejection in a timely and consistent manner. We present a detailed characterization of a porcine model of acute rejection based on swine leukocyte antigen mismatching paired with a limited period of clinically relevant immunosuppression. The result is a robust and consistent protocol that results in fulminant acute rejection of an intra-abdominally transplanted heart.


  • Open Access

    A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

    by Krish C. Dewan, Abigail R. Benkert, Alejandro A. Lobo, Jengwei Chen, Ryan T. Gross, Martha Salinas, Amy Evans, Satyanarayana Achanta, Sachin Mehta, Michael Cutrone, et al.

    The number of advanced heart failure patients who can receive a heart transplant is limited by a shortage of suitable organ donors. In efforts to expand the donor pool, alternative donation and procurement methods have been developed, including heart transplantation following donation after circulatory death (DCD HT). While short-term survival following DCD HT is non-inferior to heart transplantation with brain-dead donors, there may be an increased rate of primary graft dysfunction (PGD) associated with DCD HT allografts. The underlying etiology of PGD is multifactorial and incompletely understood. For DCD HT allografts, the period of warm ischemic injury during DCD procurement is a potential risk factor for PGD to which brain death allografts are not exposed. The functional warm ischemic time thus may be an important driver of PGD in DCD HT. However, the mechanisms underlying PGD in this clinical scenario are poorly understood at the molecular level. The work presented herein aims to describe the development and validation of a high-fidelity non-survival porcine model of DCD orthotopic heart transplantation. We hypothesize that the use of this translational large animal model is critical to elucidate molecular mechanisms contributing to PGD, as well as to investigate interventions designed to optimize allograft preservation and early performance. This model replicates the perioperative and surgical approach used in DCD HT clinically, with modifications to account for porcine anatomy and physiology. The development of this large animal surgical model will not only provide mechanistic insights into the development of PGD but also can be modified to enhance translational research efforts aimed at improving organ recovery following DCD HT.


  • JoVE Video Dataset

    by Krish C. Dewan, Abigail R. Benkert, Alejandro A. Lobo, Jengwei Chen, Ryan T. Gross, Martha Salinas, Amy Evans, Satyanarayana Achanta, Sachin Mehta, Michael Cutrone, et al.

    The number of advanced heart failure patients who can receive a heart transplant is limited by a shortage of suitable organ donors. In efforts to expand the donor pool, alternative donation and procurement methods have been developed, including heart transplantation following donation after circulatory death (DCD HT). While short-term survival following DCD HT is non-inferior to heart transplantation with brain-dead donors, there may be an increased rate of primary graft dysfunction (PGD) associated with DCD HT allografts. The underlying etiology of PGD is multifactorial and incompletely understood. For DCD HT allografts, the period of warm ischemic injury during DCD procurement is a potential risk factor for PGD to which brain death allografts are not exposed. The functional warm ischemic time thus may be an important driver of PGD in DCD HT. However, the mechanisms underlying PGD in this clinical scenario are poorly understood at the molecular level. The work presented herein aims to describe the development and validation of a high-fidelity non-survival porcine model of DCD orthotopic heart transplantation. We hypothesize that the use of this translational large animal model is critical to elucidate molecular mechanisms contributing to PGD, as well as to investigate interventions designed to optimize allograft preservation and early performance. This model replicates the perioperative and surgical approach used in DCD HT clinically, with modifications to account for porcine anatomy and physiology. The development of this large animal surgical model will not only provide mechanistic insights into the development of PGD but also can be modified to enhance translational research efforts aimed at improving organ recovery following DCD HT.

  • Open Access

    Delivery of a Muscle-Targeted Adeno-Associated Vector Via Ex Vivo Normothermic Perfusion Is Efficient, Durable, and Safe in a Preclinical Porcine Heart Transplant Model

    by Krish C. Dewan, Jeng-Wei Chen, Alejandro A. Lobo, Ryan T. Gross, Chunbo Wang, Karla G. Rivera, Keely Dieplin Tran, Smith Ngeve, Violet G. Johnston, David Wendell, et al.

    Normothermic ex-vivo organ perfusion (EVP) systems not only provide a physiological environment that preserves donor organ function outside the body but may also serve as platforms for ex-vivo organ modification via gene therapy. In this study, we demonstrated that a rationally designed muscle-tropic recombinant AAV, AAV-SLB101, delivered to the donor heart during brief normothermic EVP achieves durable cardiac transgene expression out to 90 and 120 days post-transplant in a porcine preclinical model. Moreover, transgene expression was detectable as early as 48 h post-transplant. Histological and MRI analyses of the donor myocardium showed no functional or structural impact on the allograft and no off-target gene expression in the recipient. This work will serve as a critical foundation to inform translational studies with therapeutic transgenes to improve allo-, xeno-, and auto-heart transplant outcomes.